{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,3,28]],"date-time":"2024-03-28T14:06:52Z","timestamp":1711634812043},"reference-count":11,"publisher":"Elsevier BV","issue":"1-2","license":[{"start":{"date-parts":[[2013,8,1]],"date-time":"2013-08-01T00:00:00Z","timestamp":1375315200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2013,7,16]],"date-time":"2013-07-16T00:00:00Z","timestamp":1373932800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/3.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Immunological Methods"],"published-print":{"date-parts":[[2013,8]]},"DOI":"10.1016\/j.jim.2013.05.006","type":"journal-article","created":{"date-parts":[[2013,5,23]],"date-time":"2013-05-23T14:37:13Z","timestamp":1369319833000},"page":"121-124","update-policy":"http:\/\/dx.doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":6,"title":["Optimisation of a functional mycobacterial growth-inhibition assay to improve its suitability for infant TB vaccine studies"],"prefix":"10.1016","volume":"394","author":[{"given":"S.","family":"Burl","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"B.S.","family":"Holder","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"B.K.M.","family":"Lo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"B.","family":"Kampmann","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.jim.2013.05.006_bb0005","doi-asserted-by":"crossref","first-page":"1245","DOI":"10.1016\/S0140-6736(94)90748-X","article-title":"Delayed-type hypersensitivity, mycobacterial vaccines and protective immunity","volume":"344","author":"Fine","year":"1994","journal-title":"Lancet"},{"key":"10.1016\/j.jim.2013.05.006_bb0010","doi-asserted-by":"crossref","first-page":"1073","DOI":"10.1164\/rccm.201003-0334OC","article-title":"Specific T cell frequency and cytokine expression profile do not correlate with protection against tuberculosis after bacillus Calmette\u2013Guerin vaccination of newborns","volume":"182","author":"Kagina","year":"2010","journal-title":"Am. J. Respir. Crit. Care Med."},{"key":"10.1016\/j.jim.2013.05.006_bb0015","doi-asserted-by":"crossref","first-page":"895","DOI":"10.1086\/315766","article-title":"Evaluation of human antimycobacterial immunity using recombinant reporter mycobacteria","volume":"182","author":"Kampmann","year":"2000","journal-title":"J. Infect. Dis."},{"key":"10.1016\/j.jim.2013.05.006_bb0020","doi-asserted-by":"crossref","first-page":"6401","DOI":"10.1128\/IAI.72.11.6401-6407.2004","article-title":"Novel human in vitro system for evaluating antimycobacterial vaccines","volume":"72","author":"Kampmann","year":"2004","journal-title":"Infect. Immun."},{"key":"10.1016\/j.jim.2013.05.006_bb0025","doi-asserted-by":"crossref","first-page":"1011","DOI":"10.1097\/01.aids.0000222073.45372.ce","article-title":"Reconstitution of antimycobacterial immune responses in HIV-infected children receiving HAART","volume":"20","author":"Kampmann","year":"2006","journal-title":"AIDS (London, England)"},{"key":"10.1016\/j.jim.2013.05.006_bb0030","doi-asserted-by":"crossref","first-page":"7190","DOI":"10.4049\/jimmunol.178.11.7190","article-title":"IFN-gamma- and TNF-independent vitamin D-inducible human suppression of mycobacteria: the role of cathelicidin LL-37","volume":"178","author":"Martineau","year":"2007","journal-title":"J. Immunol."},{"key":"10.1016\/j.jim.2013.05.006_bb0035","doi-asserted-by":"crossref","first-page":"177","DOI":"10.7326\/0003-4819-149-3-200808050-00241","article-title":"Systematic review: T-cell-based assays for the diagnosis of latent tuberculosis infection: an update","volume":"149","author":"Pai","year":"2008","journal-title":"Ann. Intern. Med."},{"key":"10.1016\/j.jim.2013.05.006_bb0040","doi-asserted-by":"crossref","first-page":"1190","DOI":"10.1128\/IAI.66.3.1190-1199.1998","article-title":"Expression of virulence of Mycobacterium tuberculosis within human monocytes: virulence correlates with intracellular growth and induction of tumor necrosis factor alpha but not with evasion of lymphocyte-dependent monocyte effector functions","volume":"66","author":"Silver","year":"1998","journal-title":"Infect. Immun."},{"key":"10.1016\/j.jim.2013.05.006_bb0045","doi-asserted-by":"crossref","first-page":"4586","DOI":"10.1128\/IAI.67.9.4586-4593.1999","article-title":"Assessment of immunity to mycobacterial infection with luciferase reporter constructs","volume":"67","author":"Snewin","year":"1999","journal-title":"Infect. Immun."},{"key":"10.1016\/j.jim.2013.05.006_bb0050","doi-asserted-by":"crossref","DOI":"10.1016\/S0140-6736(13)60177-4","article-title":"Safety and efficacy of MVA85A, a new tuberculosis vaccine, in infants previously vaccinated with BCG: a randomised, placebo-controlled phase 2b trial","author":"Tameris","year":"2013","journal-title":"Lancet"},{"issue":"Suppl. 3","key":"10.1016\/j.jim.2013.05.006_bb0055","doi-asserted-by":"crossref","first-page":"S257","DOI":"10.1086\/313887","article-title":"In vitro measurement of protective mycobacterial immunity: antigen-specific expansion of T cells capable of inhibiting intracellular growth of bacille Calmette\u2013Guerin","volume":"30","author":"Worku","year":"2000","journal-title":"Clin. Infect. Dis. Off. Publ. Infect. Dis. Soc. Am."}],"container-title":["Journal of Immunological Methods"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022175913001671?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022175913001671?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2020,7,27]],"date-time":"2020-07-27T02:09:16Z","timestamp":1595815756000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0022175913001671"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,8]]},"references-count":11,"journal-issue":{"issue":"1-2","published-print":{"date-parts":[[2013,8]]}},"alternative-id":["S0022175913001671"],"URL":"https:\/\/doi.org\/10.1016\/j.jim.2013.05.006","relation":{},"ISSN":["0022-1759"],"issn-type":[{"value":"0022-1759","type":"print"}],"subject":[],"published":{"date-parts":[[2013,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Optimisation of a functional mycobacterial growth-inhibition assay to improve its suitability for infant TB vaccine studies","name":"articletitle","label":"Article Title"},{"value":"Journal of Immunological Methods","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jim.2013.05.006","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2013 The Authors. Published by Elsevier B.V.","name":"copyright","label":"Copyright"}]}}